Nutra Pharma Corp (NPHC) Long-Term Deferred Tax (2016 - 2018)

Nutra Pharma has disclosed Long-Term Deferred Tax across 3 years of filings, most recently posting $9.1 million for Q4 2018.

• In Q4 2018, Long-Term Deferred Tax fell 29.0% year-over-year to $9.1 million; the TTM figure through Dec 2018 stood at $9.1 million (down 29.0% YoY), while the FY2018 annual figure was $9.1 million, down 29.0% from the prior year.
• Long-Term Deferred Tax came in at $9.1 million for Q4 2018 at Nutra Pharma, down from $12.8 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $12.8 million in Q4 2017 to a low of $9.1 million in Q4 2018.
• Average Long-Term Deferred Tax over 3 years is $11.5 million, with a median of $12.7 million recorded in 2016.
• Year-over-year, Long-Term Deferred Tax rose 0.99% in 2017 and declined 29.0% in 2018.
• Over 3 years, Long-Term Deferred Tax stood at $12.7 million in 2016, then rose by 0.99% to $12.8 million in 2017, then declined by 29.0% to $9.1 million in 2018.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $9.1 million in Q4 2018, $12.8 million in Q4 2017, and $12.7 million in Q4 2016.